Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Merrimack Pharmaceuticals Inc (MACK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 80,058
  • Shares Outstanding, K 13,343
  • Annual Sales, $ 0 K
  • Annual Income, $ -40,510 K
  • 60-Month Beta 2.54
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.61

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.54 +8.30%
on 05/08/19
6.74 -10.98%
on 04/29/19
-0.01 (-0.17%)
since 04/17/19
3-Month
5.47 +9.69%
on 04/15/19
7.50 -20.00%
on 03/20/19
+0.14 (+2.39%)
since 02/15/19
52-Week
3.34 +79.64%
on 10/19/18
10.53 -43.05%
on 06/13/18
-2.83 (-32.05%)
since 05/17/18

Most Recent Stories

More News
Merrimack Reports First Quarter 2019 Financial Results

Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK), an oncology company focused on biomarker-defined cancers, today announced its first quarter 2019 financial results for the period ended March 31, 2019.

MACK : 6.00 (+1.69%)
Uptrend Call Working As Merrimack Pharma Stock Rises 24.1% (MACK)

SmarTrend identified an Uptrend for Merrimack Pharma (NASDAQ:MACK) on January 11th, 2019 at $4.97. In approximately 4 months, Merrimack Pharma has returned 24.07% as of today's recent price of $6.16.

MACK : 6.00 (+1.69%)
Shares of MACK Up 23.7% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Merrimack Pharma (NASDAQ:MACK) on January 11th, 2019 at $4.97. In approximately 3 months, Merrimack Pharma has returned 23.67% as of today's recent price of $6.14.

MACK : 6.00 (+1.69%)
BioSurplus to Conduct Lab Asset Auction of Merrimack Pharmaceuticals in Cambridge, Massachusetts

BioSurplus, America's premier lab equipment solutions provider, announced that it will be conducting a timed online auction of laboratory assets from Merrimack Pharmaceuticals' facility in Cambridge, Massachusetts....

MACK : 6.00 (+1.69%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Merrimack Pharmaceuticals, Inc. - MACK

Pomerantz LLP is investigating claims on behalf of investors of Merrimack Pharmaceuticals, Inc. ("Merrimack" or the "Company") (NASDAQ: MACK). Such investors are advised to contact Robert S. Willoughby...

MACK : 6.00 (+1.69%)
Uptrend Call Working As Merrimack Pharma Stock Rises 21.0% (MACK)

SmarTrend identified an Uptrend for Merrimack Pharma (NASDAQ:MACK) on January 11th, 2019 at $4.97. In approximately 3 months, Merrimack Pharma has returned 21.05% as of today's recent price of $6.01.

MACK : 6.00 (+1.69%)
Report: Developing Opportunities within Eastman Chemical, Target, Federated Investors, First American Financial, Merrimack Pharmaceuticals, and LyondellBasell Industries N.V -- Future Expectations, Projections Moving into 2019

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Eastman Chemical Company (NYSE:EMN),...

TGT : 70.89 (+0.16%)
LYB : 80.15 (-2.02%)
EMN : 71.22 (-1.30%)
FII : 30.56 (-1.20%)
FAF : 54.85 (-0.60%)
MACK : 6.00 (+1.69%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Merrimack Pharmaceuticals, Inc. - MACK

Pomerantz LLP is investigating claims on behalf of investors of Merrimack Pharmaceuticals, Inc. ("Merrimack" or the "Company") (NASDAQ: MACK). Such investors are advised to contact Robert S. Willoughby...

MACK : 6.00 (+1.69%)
Merrimack Pharma Up 15.4% Since SmarTrend Uptrend Call (MACK)

SmarTrend identified an Uptrend for Merrimack Pharma (NASDAQ:MACK) on January 11th, 2019 at $4.97. In approximately 3 months, Merrimack Pharma has returned 15.41% as of today's recent price of $5.73.

MACK : 6.00 (+1.69%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Merrimack Pharmaceuticals, Inc. - MACK

Pomerantz LLP is investigating claims on behalf of investors of Merrimack Pharmaceuticals, Inc. ("Merrimack" or the "Company") (NASDAQ: MACK). Such investors are advised to contact Robert S. Willoughby...

MACK : 6.00 (+1.69%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade MACK with:

Business Summary

Merrimack Pharmaceuticals, Inc., is a biopharmaceutical company focused on the discovery, development and preparation to commercialize innovative medicines paired with companion diagnostics for the treatment of serious diseases, with a special focus on cancer. Merrimack Pharmaceuticals, Inc. is headquartered...

See More

Key Turning Points

2nd Resistance Point 6.31
1st Resistance Point 6.15
Last Price 6.00
1st Support Level 5.81
2nd Support Level 5.63

See More

52-Week High 10.53
Fibonacci 61.8% 7.79
Fibonacci 50% 6.94
Fibonacci 38.2% 6.09
Last Price 6.00
52-Week Low 3.34

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar